Browsing by Author "Willekens, B"
Now showing items 1-1 of 1
-
Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial
Cree, BAC; Cutter, G; Wolinsky, JS; Freedman, MS; Comi, G; Giovannoni, G; Hartung, H-P; Arnold, D; Kuhle, J; Block, V (Elsevier, 2020-10-23)Background There is an unmet need to develop therapeutic interventions directed at the neurodegeneration that underlies progression in multiple sclerosis. High-dose, pharmaceutical-grade biotin (MD1003) might enhance ...